Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Rhn van Schaik"'
Autor:
Mary V. Relling, Victoria M. Pratt, Michael Pacanowski, Urs A. Meyer, Deborah A. Nickerson, Ranjit K. Thirumaran, C Bruckner, Rhn van Schaik, Teri E. Klein, Kelly E. Caudle, Matthias Schwab, Elspeth A. Bruford, Toinette Hartshorne, Rachel F. Tyndale, Wendy S. Rubinstein, AL Del Tredici, Sotiria Boukouvala, Robert R. Freimuth, M Lindqvist Appell, Gillian C. Bell, A Roberts, Howard L. McLeod, Katrin Sangkuhl, Maglott, Volker M. Lauschke, Lisa V. Kalman, Ulrich M. Zanger, Robin E. Everts, Ktj Yeo, JT den Dunnen, Daniel J. Müller, Gwendolyn A. McMillin, David A. Flockhart, H Hachad, Michelle Whirl-Carrillo, Jag Agúndez, A. Gaedigk, Lorraine Toji, Sarah C. Sim, Stuart A. Scott, Katarzyna Drozda, Ann K. Daly, John L. Black, Magnus Ingelman-Sundberg, Sally A. Coulthard, William S. Oetting
Publikováno v:
Clinical Pharmacology and Therapeutics, 99(2), 172-185
Clinical Pharmacology & Therapeutics, 99(2), 172-185. Wiley-Blackwell
Clinical Pharmacology & Therapeutics, 99(2), 172-185. Wiley-Blackwell
This manuscript provides nomenclature recommendations developed by an international workgroup to increase transparency and standardization of pharmacogenetic (PGx) result reporting. Presently, sequence variants identified by PGx tests are described u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bfbf51cd9532fd1cbe69fa7e487ef33
http://hdl.handle.net/1887/113787
http://hdl.handle.net/1887/113787
Autor:
A.G. Uitterlinden, Loes E. Visser, B. H. Stricker, Albert Hofman, Rhn van Schaik, Martina Teichert, Pagm de Smet
Publikováno v:
Clinical Pharmacology & Therapeutics, 85(4), 379-386. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 85, 4, pp. 379-86
Clinical Pharmacology and Therapeutics, 85, 379-86
Clinical Pharmacology and Therapeutics, 85, 4, pp. 379-86
Clinical Pharmacology and Therapeutics, 85, 379-86
Item does not contain fulltext The objective of this study was to investigate the influence of genotypes associated with reduced activity of vitamin K epoxide reductase complex subunit 1 (VKORC1) and cytochrome P450 2C9 (CYP2C9) on anticoagulation wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74dcf534f735e0ac30c5a807b4e66b95
https://doi.org/10.1038/clpt.2008.294
https://doi.org/10.1038/clpt.2008.294
Autor:
van der Aa, Marloes P.1 m.van.der.aa@antoniusziekenhuis.nl, Elst, Marieke A. J.1 m.elst@antoniusziekenhuis.nl, van Mil, Edgar G. A. H.2 e.g.vanmil@jbz.nl, Knibbe, Catherijne A. J.3 c.knibbe@antoniusziekenhuis.nl, van der Vorst, Marja M. J.1 m.van.der.vorst@antoniusziekenhuis.nl
Publikováno v:
Trials. 2014, Vol. 15 Issue 1, p1-19. 19p. 1 Diagram, 3 Charts.
Publikováno v:
Pharmacogenomics Journal. Oct2011, Vol. 11 Issue 5, p359-367. 9p.
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. Jul2010 Supplement 1, Vol. 107, p162-692. 531p.
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. Jul2010 Supplement 1, Vol. 107, p698-757. 60p.
Autor:
Schenk, PW1, Vliet, M. van1, Mathot, RAA2, Gelder, T. van2, Vulto, AG2, Fessem, MAC van1, Rij, S Verploegh-Van3, Lindemans, J1, Bruijn, JA3, Schaik, RHN van1 r.vanschaik@erasmusmc.nl
Publikováno v:
Pharmacogenomics Journal. Jun2010, Vol. 10 Issue 3, p219-225. 7p. 3 Charts, 1 Graph.
Autor:
Schenk, P. W.1, van Fessem, M. A. C.1, Verploegh-Van Rij, S.2, Mathot, R. A. A.3, van Gelder, T.3, Vulto, A. G.3, van Vliet, M.1, Lindemans, J.1, Bruijn, J. A.2, van Schaik, R. H. N.1 r.vanschaik@erasmusmc.nl
Publikováno v:
Molecular Psychiatry. Jun2008, Vol. 13 Issue 6, p597-605. 9p. 2 Charts, 3 Graphs.
Autor:
Schaik, R H N van, Wierikx, C D J, Timmerman, M A, Oomen, M H, Weerden, W M van, Kwast, T H van der, Steenbrugge, G J van, Jong, F H de
Publikováno v:
British Journal of Cancer. 1/1/2000, Vol. 82 Issue 1, p112. 6p.
Publikováno v:
Drug Metabolism & Personalized Therapy; Dec2016, Vol. 31 Issue 4, peA19-eA62, 44p